# Targeting Cognition in Bipolar Disorder With Pramipexole

> **NCT02397837** · PHASE4 · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 103 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Pramipexole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02397837
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2018-07-26
- **Final completion:** 2018-07-26
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2020-02-28

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02397837

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02397837, "Targeting Cognition in Bipolar Disorder With Pramipexole". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02397837. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*